Apalutamide Tablets

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

BHP explores a potential $2 billion sale of Chilean desalination and electricity transmission assets supporting its major copper operations. Representative image.

BHP (ASX: BHP) explores $1.5-$2bn sale of Chilean desalination plant and power lines

Vodafone shares surge after Xavier Niel’s Vega agrees to acquire e&’s 16.21 percent stake in a £4.4 billion transaction. Representative image.

Vodafone (LSE: VOD) jumps 12% as Xavier Niel’s Vega buys e&’s 16.21% stake for £4.4bn

GlobalWafers and Micron Technology expand United States semiconductor supply capacity through a $500 million financing and 10-year silicon wafer agreement. Representative image.

GlobalWafers locks in $500m Micron financing and 10-year Sherman wafer supply pact

Ukraine’s new long-range strike command intensifies its campaign against Russian oil refineries, fuel infrastructure and wartime logistics networks. Representative image.

Ukraine’s drone war enters new phase with dedicated command targeting Russia

Zydus Lifesciences enters $1.09bn prostate cancer drug market with USFDA green light

Zydus Lifesciences gains USFDA approval for Apalutamide Tablets, 60 mg, expanding its oncology generics portfolio. Find out what this means for investors.

byPallavi Madhiraju

March 19, 2025

Lupin Limited secures tentative FDA nod for generic Apalutamide Tablets

In a significant stride for global pharmaceuticals, Lupin Limited has garnered tentative approval from the United States Food…

byPallavi Madhiraju

October 13, 2023

The Latest

BHP (ASX: BHP) explores $1.5-$2bn sale of Chilean desalination plant and power lines

Vodafone (LSE: VOD) jumps 12% as Xavier Niel’s Vega buys e&’s 16.21% stake for £4.4bn

GlobalWafers locks in $500m Micron financing and 10-year Sherman wafer supply pact

Ukraine’s drone war enters new phase with dedicated command targeting Russia

Zydus Lifesciences enters $1.09bn prostate cancer drug market with USFDA green light

Lupin Limited secures tentative FDA nod for generic Apalutamide Tablets

BHP (ASX: BHP) explores $1.5-$2bn sale of Chilean desalination plant and power lines

Vodafone (LSE: VOD) jumps 12% as Xavier Niel’s Vega buys e&’s 16.21% stake for £4.4bn

GlobalWafers locks in $500m Micron financing and 10-year Sherman wafer supply pact

Ukraine’s drone war enters new phase with dedicated command targeting Russia

Victoria PLC (AIM: VCP) holds refinancing rally as £300m debt cut tests flooring recovery

Baltic Power offshore wind farm sends first electricity to Poland’s grid as ORLEN and Northland near completion

SK Hynix (SKHYV) Nasdaq debut raises $26.5bn, second-largest US IPO ever after SpaceX

Almonty Industries (ALM) jumps 11% as DA Davidson lifts PT to $33 on tungsten thesis